Acadia Pharmaceuticals | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
ALKERMES USD 505.96M 62.23M 2025-06
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Corcept Therapeutics USD 143.07M 2.29M 2025-03
Cytokinetics USD 159.73M 19.95M 2025-03
Eisai JPY 372.29B 9.32B 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Incyte USD 1.28B 608.18M 2025-06
J&J USD 56.9B 6.58B 2025-03
Moderna USD 1.6B 602M 2025-03
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
Pfizer USD 36.45B 6.54B 2025-03
Prothena USD 48.5M 2.08M 2024-12
PTC Therapeutics USD 595.39M 14.41M 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12


Acadia Pharmaceuticals Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.